RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
TransEnterix, Inc. (NYSE American: TRXC) announced today that Joseph P.
Slattery, Executive Vice President and Chief Financial Officer, will
present at two upcoming investor conferences:
Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September
26, 2017 at 4:00 pm Eastern Time at the Sofitel New York Hotel.
Cantor Fitzgerald Global Healthcare Conference on Wednesday, September
27, 2017 at 9:10 am Eastern Time at the InterContinental New York
TransEnterix is a medical device company that is pioneering the use of
robotics to improve minimally invasive surgery by addressing the
clinical and economic challenges associated with current laparoscopic
and robotic options. The company is focused on the commercialization of
the Senhance Surgical Robotic System, a multi-port robotic system that
brings the advantages of robotic surgery to patients while enabling
surgeons with innovative technology such as haptic feedback and eye
sensing camera control. The company is also developing the SurgiBot™
System, a single-port, robotically enhanced laparoscopic surgical
platform. The Senhance Surgical Robotic System has been granted a CE
Mark, and is currently under FDA review for clearance in the United
States. For more information, visit the TransEnterix website at www.transenterix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170912005546/en/
For TransEnterix, Inc.
For EU: Conrad Harrington, +44 (0)20 3178 8914
US: Hannah Dunning, +1-415-618-8750
News Provided by Acquire Media